Skip to main content
. 2021 Aug;12(4):1326–1337. doi: 10.21037/jgo-21-123

Table 3. Peritoneal recurrence according to the clinicopathological factors.

Variables Peritoneal recurrence (number of patients, %)
No Yes P value
Age
   <60 90 (79.6) 23 (20.4) 0.118
   ≥60 73 (88.0) 10 (12.0)
Sex
   Male 57 (43.5) 74 (56.5) 0.254
   Female 22 (34.9) 41 (65.1)
Grade/differentiation
   Well/moderately differentiated 51 (87.9) 7 (12.1) 0.239
   Poorly differentiated 112 (81.0) 26 (19.0)
Histology
   Signet ring cell 140 (85.9) 23 (14.1) 0.301
   Non-signet ring cell 26 (78.8) 7 (21.2)
Lauren classification
   Intestinal 99 (86.8) 15 (13.2) 0.096
   Diffuse 64 (78.0) 18 (22.0)
Primary location
   Upper 1/3 32 (84.2) 6 (15.8) 0.451
   Middle & lower 1/3 130 (83.3) 26 (16.7)
   Whole 1 (50.0) 1 (50.0)
Lymphovascular invasion
   Negative 13 (86.7) 2 (13.3) 0.705
   Positive 145 (82.9) 30 (17.1)
Perineural invasion
   Negative 67 (87.0) 10 (13.0) 0.439
   Positive 90 (80.4) 22 (19.6)
pT stage
   T1 3 (100.0) 0 (0.0) 0.138
   T2 21 (95.5) 1 (4.5)
   T3 66 (85.7) 11 (14.3)
   T4 73 (77.4) 21 (22.6)
pN stage
   N0 16 (80.0) 4 (20.0) 0.009*
   N1 44 (97.8) 1 (2.2)
   N2 57 (83.6) 11 (16.4)
   N3 46 (73.0) 17 (27.0)

*, Statistically significant (P<0.05).